Literature DB >> 9261161

Interaction and regulation of the Caenorhabditis elegans death protease CED-3 by CED-4 and CED-9.

D Wu1, H D Wallen, N Inohara, G Nuñez.   

Abstract

In the nematode Caenorhabditis elegans, three genes, ced-3, ced-4, and ced-9, play critical roles in the induction and execution of the death pathway. Genetic studies have suggested that ced-9 controls programmed cell death by regulating ced-4 and ced-3. However, the mechanism by which CED-9 controls the activities of CED-4 and the cysteine protease CED-3, the effector arm of the cell-death pathway, remains poorly understood. Immunoprecipitation analysis demonstrates that CED-9 forms a multimeric protein complex with CED-4 and CED-3 in vivo. Expression of wild-type CED-4 promotes the ability of CED-3 to induce apoptosis in mammalian cells, which is inhibited by CED-9. The pro-apoptotic activity of CED-4 requires the expression of a functional CED-3 protease. Significantly, loss-of-function CED-4 mutants are impaired in their ability to promote CED-3-mediated apoptosis. Expression of CED-4 enhances the proteolytic activation of CED-3. We also show that CED-9 inhibits the formation of p13 and p15, two cleavage products of CED-3 associated with its proteolytic activation in vivo. Moreover, CED-9 inhibits the enzymatic activity of CED-3 promoted by CED-4. Thus, these results provide evidence that CED-4 and CED-9 regulate the activity of CED-3 through physical interactions, which may provide a molecular basis for the control of programmed cell death in C. elegans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261161     DOI: 10.1074/jbc.272.34.21449

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  The apoptosome: heart and soul of the cell death machine.

Authors:  A M Chinnaiyan
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 2.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 3.  Targeting cancer cell death with a bcl-XS adenovirus.

Authors:  J S Han; G Núñez; M S Wicha; M F Clarke
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.

Authors:  A J Minn; C S Kettlun; H Liang; A Kelekar; M G Vander Heiden; B S Chang; S W Fesik; M Fill; C B Thompson
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

5.  Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: implicated mechanisms for caspase activation.

Authors:  H Kanuka; S Hisahara; K Sawamoto; S Shoji; H Okano; M Miura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

6.  Hox and a newly identified E2F co-repress cell death in Caenorhabditis elegans.

Authors:  Jennifer Winn; Monique Carter; Leon Avery; Scott Cameron
Journal:  Genetics       Date:  2011-05-19       Impact factor: 4.562

7.  The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.

Authors:  D C Huang; J M Adams; S Cory
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

8.  CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor.

Authors:  N Inohara; T Koseki; S Chen; X Wu; G Núñez
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

9.  ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases.

Authors:  T Koseki; N Inohara; S Chen; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

10.  ALG-2/AGO-Dependent mir-35 Family Regulates DNA Damage-Induced Apoptosis Through MPK-1/ERK MAPK Signaling Downstream of the Core Apoptotic Machinery in Caenorhabditis elegans.

Authors:  Markus Alexander Doll; Najmeh Soltanmohammadi; Björn Schumacher
Journal:  Genetics       Date:  2019-07-11       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.